Stemmatters can assure all manufacturing steps from material reception through to fill & finish, storage and retrieval. Our integrated QMS ensures complete continuity in the chain of identity and custody, mitigating traceability risk and providing total transparency over our supply chain operations. We operate with a range of cell types, including dendritic cells, T-cells, natural killer (NK) cells, pluripotent stem cells, mesenchymal stromal cells (MSCs) and more.
ATMPs are provided according to validated standard operating procedures (SOPs), compliant with regulation (EC) No. 1394/2007. Manufacturing at Stemmatters is provided under full cGMP compliance.
We have experience with isolating blood-derived compounds and producing cell-derived biologics. Stemmatters provides manufacturing and supply services for biological products, and can assist in sourcing of starting materials.
Further to respecting our in-house quality practices, we work closely with our partners to ensure their own quality programs are robustly implemented into our manufacturing service practicess.
Stemmatters offers services to develop and implement procedures for isolation and banking of a large variety of human cells, and to establish and maintain master cell banks (MCB) and working cell banks (WCB). Establishing a cell bank ensures a ready and sustainable supply of starting material that is fully qualified according to quality specification.
Storage can be performed in vials and/or bags, in vapour phase liquid nitrogen or in freezers. Cell characterisation and functional assays can be deployed to validate shelf life and storage properties of materials and cells.
Stemmatters develops solutions to meet challenges and requirements of aseptic fill & finish of biopharmaceuticals and ATMPs.
Stemmatters offers a full range of cost-effective services to develop, implement and validate process-end aseptic fill & finish procedures suitable for your product across a range of technology domains, in compliance with cGMP requirements.